Youjia Bio

BiotechnologySeries AHangzhou, China

Latest round

Series A

Last raised

Sep 2022

Total raised

Undisclosed

Investors

1

About Youjia Bio

, Ltd is a biomedicine company that focuses on research and development of nucleic acid drug. The company's self-developed nucleic acid drug development platform includes a nucleic acid drug intelligent design NDDS (Novel Drug Delivery Systems) system, a mature delivery system, a complete drug evaluation platform and a polymer based multi-dose formulation platform. The products are used in the field of anti-virus, anti-fibrosis and cardiovascular disease.

Who invested in Youjia Bio

1 investor across 1 round

See all investors in Youjia Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 23, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Youjia Bio

Who invested in Youjia Bio?

Youjia Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Youjia Bio raised?

Youjia Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Youjia Bio last raise money?

Youjia Bio's most recent round on record is a Series A, in Sep 2022.

What does Youjia Bio do?

, Ltd is a biomedicine company that focuses on research and development of nucleic acid drug.

Where is Youjia Bio headquartered?

Youjia Bio is headquartered in Hangzhou, China.

Which VCs invest in companies like Youjia Bio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Youjia Bio's stage. Their profiles are linked below.

Raising like Youjia Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.